Comparing Asthma Treatments: Salmeterol/Fluticasone vs. Fluticasone Alone
Author Information
Author(s): Catherine M Houghton, Naomi Lawson, Zoe L Borrill, Claire L Wixon, Sally Yoxall, Stephen J Langley, Ashley Woodcock, Dave Singh
Primary Institution: North West Lung Research Centre, South Manchester University Hospitals Trust, Manchester, UK
Hypothesis
Does the combination of salmeterol and fluticasone improve lung function more than fluticasone alone in adults with mild persistent asthma?
Conclusion
The combination of salmeterol and fluticasone is more effective than fluticasone alone in improving airway resistance in adults with mild asthma.
Supporting Evidence
- SFC caused a significantly greater reduction in airway resistance compared to FP at weeks 2 and 4.
- FEV1 was significantly higher in the SFC group at week 2.
- The study demonstrated that sensitive measurements like plethysmography are better for detecting changes in lung function than spirometry.
Takeaway
Using a combination of two asthma medications helps people breathe better than using just one medication.
Methodology
Adult patients with mild persistent asthma were randomized to receive either fluticasone propionate or a combination of salmeterol and fluticasone for four weeks, with lung function measured using plethysmography, spirometry, and impulse oscillometry.
Potential Biases
Potential bias due to funding from GlaxoSmithKline, the manufacturer of the combination therapy.
Limitations
The study was limited to a single center and may not be generalizable to all populations.
Participant Demographics
39 adults with mild persistent asthma, average age around 40 years, with a mix of male and female participants.
Statistical Information
P-Value
p<0.001
Confidence Interval
0.66 – 0.89
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website